| Literature DB >> 29894512 |
Daniela Schmid1, Charles E Matthews2, Michael F Leitzmann1.
Abstract
BACKGROUND: The relations of physical activity and sedentary behavior to mortality risk among patients with renal cell cancer have not yet been evaluated.Entities:
Mesh:
Year: 2018 PMID: 29894512 PMCID: PMC5997343 DOI: 10.1371/journal.pone.0198995
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Baseline characteristics of study participants diagnosed with incident renal cell cancer according to increasing levels of post-diagnosis moderate to vigorous physical activity and TV viewing.
| Characteristics | Post-diagnosis physical activity | Post-diagnosis TV viewing | |||||
|---|---|---|---|---|---|---|---|
| <1 hr/wk | 1 to <3 hrs/wk | ≥3 to <7 hrs/wk | ≥7 hrs/wk | 0 to 2 hrs/d | >2 to 4 hrs/d | >4 hrs/d | |
| Number of participants | 193 | 184 | 130 | 160 | 230 | 240 | 157 |
| Age at exposure assessment, years, mean | 72.3 | 70.6 | 71.0 | 71.2 | 70.9 | 71.6 | 71.8 |
| Age at diagnosis, years, mean | 68.9 | 67.0 | 67.1 | 67.4 | 67.2 | 68.1 | 67.9 |
| Sex, % | |||||||
| Men | 66 | 68 | 77 | 82 | 69 | 79 | 69 |
| Women | 34 | 32 | 23 | 18 | 31 | 21 | 31 |
| Non-Hispanic White, % | 88.0 | 89.4 | 94.3 | 91.2 | 89.2 | 89.8 | 91.7 |
| Smoking status, % | |||||||
| Never smoker | 32.2 | 33.0 | 33.6 | 29.9 | 35.7 | 29.56 | 26.2 |
| Past smoker | 46.7 | 46.7 | 58.1 | 53.1 | 49.5 | 52.4 | 52.1 |
| Current smoker | 7.0 | 6.5 | 0.7 | 4.3 | 2.7 | 5.9 | 8.5 |
| College graduate/post graduate, % | 28.4 | 36.4 | 50.8 | 47.9 | 44.6 | 40.4 | 28.7 |
| Body mass index, kg/m2 | 29.44 | 28.53 | 28.11 | 27.70 | 28.2 | 27.7 | 30.2 |
| Alcohol intake, g/d, mean | 5.7 | 9.7 | 10.7 | 11.5 | 11.4 | 9.4 | 5.9 |
| History of diabetes, % | 15.6 | 10.0 | 8.9 | 9.9 | 7.6 | 11.8 | 15.3 |
| History of high blood pressure, % | 65 | 46.7 | 53.6 | 32.1 | 46.1 | 50.2 | 58.4 |
| First course of treatment, % | |||||||
| Surgery | 36.8 | 43.2 | 51.0 | 40.9 | 47.0 | 38.2 | 39.9 |
| Chemotherapy | 2.1 | 3.4 | 2.8 | 0.6 | 1.3 | 3.3 | 1.7 |
| Radiation | 3.1 | 3.2 | 3.4 | 4.3 | 4.0 | 3.4 | 3.1 |
| Immunotherapy | 1.1 | 0.5 | 0 | 0.6 | 0.4 | 0.8 | 0 |
| Tumor summary stage, % | |||||||
| In situ | 0 | 0 | 0 | 0.7 | 0.6 | 0 | 0 |
| Localized | 81.1 | 79.4 | 83.3 | 83.1 | 81.1 | 77.9 | 85.8 |
| Regional metastases | 14.7 | 18.7 | 16.7 | 14.0 | 16.7 | 18.8 | 12.8 |
| Distant metastases | 4.2 | 1.9 | 0 | 2.2 | 1.6 | 3.3 | 1.4 |
All values (except age) are standardized to the age distribution of the study population. Categories may not sum to 100% due to missing data. Covariates were assessed in the baseline questionnaire/risk factor questionnaire (hypertension variable), except smoking status and body mass index, which were assessed in the follow-up questionnaire.
Hazard ratios and 95% confidence intervals of mortality among individuals diagnosed with renal cell cancer according to post-diagnosis moderate to vigorous physical activity.
| Post-diagnosis physical activity | |||||
|---|---|---|---|---|---|
| <1 hr/wk | 1 to <3 hrs/wk | ≥3 to <7 hrs/wk | ≥7 hrs/wk | ||
| Deaths | 56 | 55 | 33 | 31 | |
| Model 1 | 1.00 | 1.07 (0.73–1.55) | 0.85 (0.55–1.31) | 0.62 (0.40–0.97) | 0.02 |
| Model 2 | 1.00 | 1.16 (0.78–1.72) | 0.94 (0.60–1.49) | 0.60 (0.38–0.96) | 0.03 |
| Model 3 | 1.00 | 1.15 (0.77–1.70) | 0.95 (0.60–1.50) | 0.60 (0.38–0.96) | 0.03 |
| Deaths | 21 | 16 | 10 | 10 | |
| Model 1 | 1.00 | 0.83 (0.43–1.60) | 0.72 (0.34–1.55) | 0.57 (0.27–1.23) | 0.15 |
| Model 2 | 1.00 | 0.96 (0.47–1.99) | 1.07 (0.47–2.44) | 0.59 (0.25–1.38) | 0.33 |
| Model 3 | 1.00 | 0.92 (0.44–1.91) | 1.04 (0.45–2.37) | 0.57 (0.24–1.33) | 0.30 |
Model 1: adjusted for age at exposure assessment (continuous), age at cancer diagnosis (continuous), and sex.
Model 2: adjusted for all variables in Model 1 and additionally adjusted for education (less than 12 yrs, 12 yrs, vocational training or some college education, college graduate/postgraduate, unknown), ethnicity (non-Hispanic White, non-Hispanic Black, other, unknown), history of diabetes (yes, no), history of hypertension (yes, no, missing), smoking from the follow-up questionnaire (never smoker, stopped smoking 10 or more years ago, stopped smoking 5–9 years ago, stopped smoking 1–4 years ago, stopped smoking within last year, currently smoking, unknown), alcohol consumption (0, 0.1 to 14.9, ≥15g/d), surgery (yes, no, unknown/missing), chemotherapy (yes, no, unknown/missing), radiation (yes, no, unknown/missing), stage (in situ, localized, regional metastases, distant metastases, unknown/not abstracted/missing), and total sitting time (0 to 5 hrs/d, 5 to 8 hrs/d, >8 hrs/d).
Model 3: adjusted for all variables in Model 2 and additionally adjusted for body mass index from the follow-up questionnaire (18.5-<25.0 kg/m2, 25.0-<30.0 kg/m2, 30.0-<35.kg/m2, 35-<65 kg/m2, missing).
Hazard ratios and 95% confidence intervals of mortality among individuals diagnosed with renal cell cancer according to post-diagnosis TV viewing.
| Post-diagnosis TV viewing | ||||
|---|---|---|---|---|
| 0 to 2 hrs/d | >2 to 4 hrs/d | >4 hrs/d | ||
| Deaths | 49 | 65 | 49 | |
| Model 1 | 1.00 | 1.25 (0.86–1.82) | 1.52 (1.02–2.26) | 0.04 |
| Model 2 | 1.00 | 1.24 (0.83–1.86) | 1.44 (0.92–2.24) | 0.11 |
| Model 3 | 1.00 | 1.24 (0.83–1.86) | 1.44 (0.92–2.25) | 0.11 |
| Deaths | 17 | 24 | 12 | |
| Model 1 | 1.00 | 1.35 (0.72–2.53) | 1.08 (0.51–2.26) | 0.75 |
| Model 2 | 1.00 | 1.42 (0.70–2.88) | 1.02 (0.44–2.36) | 0.90 |
| Model 3 | 1.00 | 1.39 (0.68–2.84) | 1.03 (0.45–2.40) | 0.87 |
HR = hazard ratio, CI = confidence interval
Model 1: adjusted for age at exposure assessment (continuous), age at cancer diagnosis (continuous), and sex.
Model 2: adjusted for all variables in Model 1 and additionally adjusted for education (less than 12 yrs, 12 yrs, vocational training or some college education, college graduate/postgraduate, unknown), ethnicity (non-Hispanic White, non-Hispanic Black, other, unknown), history of diabetes (yes, no), history of hypertension (yes, no, missing), smoking from the follow-up questionnaire (never smoker, stopped smoking 10 or more years ago, stopped smoking 5–9 years ago, stopped smoking 1–4 years ago, stopped smoking within last year, currently smoking, unknown), alcohol consumption (0, 0.1 to 14.9, ≥15g/d), surgery (yes, no, unknown/missing), chemotherapy (yes, no, unknown/missing), radiation (yes, no, unknown/missing), stage (in situ, localized, regional metastases, distant metastases, unknown/not abstracted/missing), and moderate to vigorous physical activity (<1 hr/wk, 1 to <3 hrs/wk, ≥3 to <7 hrs/wk, and ≥7 hrs/wk).
Model 3: adjusted for all variables in Model 2 and additionally adjusted for body mass index from the follow-up questionnaire (18.5-<25.0 kg/m2, 25.0-<30.0 kg/m2, 30.0-<35.kg/m2, 35-<65 kg/m2, missing).
Hazard ratios and 95% confidence intervals of mortality among individuals diagnosed with renal cell cancer according to post-diagnosis total sitting time.
| Post-diagnosis total sitting time | ||||
|---|---|---|---|---|
| 0 to 5 hrs/d | >5 to 8 hrs/d | >8 hrs/d | ||
| Deaths | 43 | 50 | 71 | |
| Model 1 | 1.00 | 1.05 (0.70–1.58) | 1.16 (0.79–1.69) | 0.45 |
| Model 2 | 1.00 | 0.97 (0.63–1.50) | 1.13 (0.74–1.71) | 0.55 |
| Model 3 | 1.00 | 1.00 (0.65–1.56) | 1.16 (0.76–1.77) | 0.48 |
| Deaths | 15 | 20 | 19 | |
| Model 1 | 1.00 | 1.24 (0.63–2.43) | 0.88 (0.45–1.74) | 0.73 |
| Model 2 | 1.00 | 1.48 (0.70–3.15) | 1.19 (0.54–2.62) | 0.64 |
| Model 3 | 1.00 | 1.51 (0.70–3.25) | 1.24 (0.56–2.74) | 0.57 |
HR = hazard ratio, CI = confidence interval
Model 1: adjusted for age at exposure assessment (continuous), age at cancer diagnosis (continuous), and sex.
Model 2: adjusted for all variables in Model 1 and additionally adjusted for education (less than 12 yrs, 12 yrs, vocational training or some college education, college graduate/postgraduate, unknown), ethnicity (non-Hispanic White, non-Hispanic Black, other, unknown), history of diabetes (yes, no), history of hypertension (yes, no, missing), smoking from the follow-up questionnaire (never smoker, stopped smoking 10 or more years ago, stopped smoking 5–9 years ago, stopped smoking 1–4 years ago, stopped smoking within last year, currently smoking, unknown), alcohol consumption (0, 0.1 to 14.9, ≥15g/d), surgery (yes, no, unknown/missing), chemotherapy (yes, no, unknown/missing), radiation (yes, no, unknown/missing), stage (in situ, localized, regional metastases, distant metastases, unknown/not abstracted/missing), and moderate to vigorous physical activity (<1 hr/wk, 1 to <3 hrs/wk, ≥3 to <7 hrs/wk, and ≥7 hrs/wk).
Model 3: adjusted for all variables in Model 2 and additionally adjusted for body mass index from the follow-up questionnaire (18.5-<25.0 kg/m2, 25.0-<30.0 kg/m2, 30.0-<35.kg/m2, 35-<65 kg/m2, missing).